Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Early Use of Rituximab for Rapidly Progressive Interstital Lung Disease Associated With an Anti-PL-12 Antisynthetase Syndrome — Usman Nazir (2014) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Early Use of Rituximab for Rapidly Progressive Interstital Lung Disease Associated With an Anti-PL-12 Antisynthetase Syndrome
Shared by
Michael R Hamblin
Early Use of Rituximab for Rapidly Progressive Interstital Lung Disease Associated With an Anti-PL-12 Antisynthetase Syndrome
Article
2014
en
Authors
UN
Usman Nazir
Michael R Hamblin
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Letter
2006
Rapidly progressive dilatation of coronary artery aneurysm associated with Kawasaki disease
Jae Il Shin
,
Jae Young Choi
,
Jun Hee Sul
,
Dong Soo Kim
,
Young Hwan Park
Letter
2012
Role of Interleukin-12 and - 18 in Lupus-like Syndrome Patients with Statin Use
Se Jin Park
,
Jae Il Shin
Article
1992
Paraneoplastic Cushing's syndrome as an adverse prognostic factor in patients who die early with small cell lung cancer
Meletios A Dimopoulos
,
José Francisco Juanmartiñena Fernández
,
Naguib A. Samaan
,
Paul Y. Holoye
,
Rena Vassilopoulou‐Sellin
Article
1994
Capillaritis (purpura simplex) associated with use of aminoglutethimide in Cushing’s syndrome
Constantine A. Stratakis
,
George Chrousos
Article
1998
Increased sensitivity of the cough reflex in progressive systemic sclerosis patients with interstitial lung disease
Umesh Lalloo
,
Seung-Kwan Lim
,
R.M. duBois
,
Peter J Barnes
,
Kian Fan Chung
Discussion(0)
No comments yet. Be the first to comment.